HK1107000A1 - A method for the prevention of thromboembolic disorders - Google Patents
A method for the prevention of thromboembolic disordersInfo
- Publication number
- HK1107000A1 HK1107000A1 HK07112472.5A HK07112472A HK1107000A1 HK 1107000 A1 HK1107000 A1 HK 1107000A1 HK 07112472 A HK07112472 A HK 07112472A HK 1107000 A1 HK1107000 A1 HK 1107000A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- prevention
- thromboembolic disorders
- thromboembolic
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20040674A FI20040674A0 (fi) | 2004-05-12 | 2004-05-12 | Menetelmä tromboembolisten sairauksien estoon |
PCT/FI2005/000220 WO2005107757A2 (en) | 2004-05-12 | 2005-05-12 | A method for the prevention of thromboembolic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1107000A1 true HK1107000A1 (en) | 2008-03-28 |
Family
ID=32338383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07112472.5A HK1107000A1 (en) | 2004-05-12 | 2007-11-15 | A method for the prevention of thromboembolic disorders |
Country Status (16)
Country | Link |
---|---|
US (2) | US8017609B2 (es) |
EP (1) | EP1744752A2 (es) |
JP (1) | JP5074923B2 (es) |
KR (1) | KR20080020930A (es) |
CN (1) | CN1980673B (es) |
AR (1) | AR050903A1 (es) |
AU (1) | AU2005239847B2 (es) |
CA (1) | CA2564033A1 (es) |
EA (1) | EA010890B1 (es) |
FI (1) | FI20040674A0 (es) |
HK (1) | HK1107000A1 (es) |
NO (1) | NO20065669L (es) |
NZ (3) | NZ579537A (es) |
TW (1) | TWI366463B (es) |
WO (1) | WO2005107757A2 (es) |
ZA (1) | ZA200609304B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20040674A0 (fi) * | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
WO2006087420A2 (en) * | 2005-02-18 | 2006-08-24 | Orion Corporation | A method for treating heart failure |
JP2010514778A (ja) * | 2006-12-28 | 2010-05-06 | オリオン コーポレーション | 非経口投与のためのレボシメンダン製剤 |
TW200920371A (en) | 2007-08-29 | 2009-05-16 | Orion Corp | A combination treatment |
WO2010097501A2 (en) * | 2009-02-26 | 2010-09-02 | Orion Corporation | A combination treatment |
WO2011027021A1 (en) | 2009-09-01 | 2011-03-10 | Orion Corporation | A method for the treatment of hypertension |
EP2322163A1 (en) * | 2009-11-03 | 2011-05-18 | Pharnext | New therapeutics approaches for treating alzheimer disease |
KR101910153B1 (ko) * | 2016-11-04 | 2018-10-19 | 한국과학기술연구원 | 타우 관련 질환의 예방 또는 치료용 레보시멘단 화합물 |
WO2019216589A1 (ko) * | 2018-05-09 | 2019-11-14 | 한국과학기술연구원 | 타우 관련 질환의 예방 또는 치료용 조성물 |
CA3161960A1 (en) | 2019-12-16 | 2021-06-24 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef) |
CN115518037A (zh) * | 2022-10-14 | 2022-12-27 | 上药东英(江苏)药业有限公司 | 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1468111A (en) * | 1976-01-08 | 1977-03-23 | Pfizer Ltd | Thiophene-sulphonamides |
DE3209159A1 (de) * | 1982-03-13 | 1983-09-15 | Basf Ag, 6700 Ludwigshafen | Neue 6-aryl-4,5-dihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung, diese verbindungen enthaltende therapeutische mittel und deren verwendung |
JPS63141970A (ja) * | 1986-12-04 | 1988-06-14 | Morishita Seiyaku Kk | 4,5−ジヒドロ−6−(4−置換フエニル)−3(2h)−ピリダジノン誘導体 |
GB2251615B (en) | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
GB2266841A (en) * | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
US5945432A (en) * | 1995-12-22 | 1999-08-31 | The University Of Vermont And State Agricultural College | Thrombolytic agents and thienopyridine derivatives in acute stroke |
EP1008348A4 (en) * | 1997-02-27 | 2001-04-04 | Ajinomoto Kk | THROMBOLYTIC AGENT |
FI974578A (fi) * | 1997-12-19 | 1999-06-20 | Orion Yhtymae Oyj | Menetelmä levosimendaanin antamiseksi |
US5905078A (en) | 1998-06-19 | 1999-05-18 | Orion Corporation | Use of a pyridazinone derivative |
FI20001542A (fi) * | 2000-06-29 | 2001-12-30 | Orion Yhtymae Oyj | Menetelmä septisen sokin hoitamiseksi |
FI20011464A0 (fi) * | 2001-07-04 | 2001-07-04 | Orion Corp | Yhdistelmäterapia sydämen vajaatoiminnan hoitoon |
FI20011465A0 (fi) | 2001-07-04 | 2001-07-04 | Orion Corp | Pyridatsinonijohdannaisen uusi käyttö |
PT1430045E (pt) * | 2001-09-21 | 2007-01-31 | Novartis Ag | Derivados de pirano como inibidores de ace e nep |
FI20020197A0 (fi) | 2002-02-01 | 2002-02-01 | Orion Corp | Yhdistelmä akuutin myokardiilisen infarktin hoitoon |
FI20030015A0 (fi) * | 2003-01-03 | 2003-01-03 | Orion Corp | Menetelmä munuaisten vajaatoiminnan hoitamiseksi |
EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
FI20040674A0 (fi) * | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
CN101031302A (zh) * | 2004-05-28 | 2007-09-05 | 艾博特公司 | 用于治疗心脏停搏前、期间和之后的哺乳动物的方法 |
WO2006087420A2 (en) * | 2005-02-18 | 2006-08-24 | Orion Corporation | A method for treating heart failure |
DK1951227T3 (en) | 2005-11-14 | 2017-07-10 | Boehringer Ingelheim Vetmedica Gmbh | APPLICATION OF PIMOBENDAN TO TREAT ASYMPTOMATIC (OCCULT) HEART FAILURE |
-
2004
- 2004-05-12 FI FI20040674A patent/FI20040674A0/fi not_active Application Discontinuation
-
2005
- 2005-04-28 TW TW094113669A patent/TWI366463B/zh not_active IP Right Cessation
- 2005-05-11 AR ARP050101922A patent/AR050903A1/es not_active Application Discontinuation
- 2005-05-12 NZ NZ579537A patent/NZ579537A/en not_active IP Right Cessation
- 2005-05-12 KR KR1020067023504A patent/KR20080020930A/ko not_active Application Discontinuation
- 2005-05-12 CN CN2005800142213A patent/CN1980673B/zh not_active Expired - Fee Related
- 2005-05-12 AU AU2005239847A patent/AU2005239847B2/en not_active Ceased
- 2005-05-12 WO PCT/FI2005/000220 patent/WO2005107757A2/en active Application Filing
- 2005-05-12 JP JP2007512237A patent/JP5074923B2/ja not_active Expired - Fee Related
- 2005-05-12 EP EP05739367A patent/EP1744752A2/en not_active Withdrawn
- 2005-05-12 NZ NZ579536A patent/NZ579536A/en not_active IP Right Cessation
- 2005-05-12 US US11/596,064 patent/US8017609B2/en not_active Expired - Fee Related
- 2005-05-12 CA CA002564033A patent/CA2564033A1/en not_active Abandoned
- 2005-05-12 EA EA200602096A patent/EA010890B1/ru not_active IP Right Cessation
- 2005-05-12 NZ NZ550814A patent/NZ550814A/en not_active IP Right Cessation
-
2006
- 2006-11-08 ZA ZA200609304A patent/ZA200609304B/en unknown
- 2006-12-08 NO NO20065669A patent/NO20065669L/no not_active Application Discontinuation
-
2007
- 2007-11-15 HK HK07112472.5A patent/HK1107000A1/xx not_active IP Right Cessation
-
2011
- 2011-08-11 US US13/207,537 patent/US8329693B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2007537209A (ja) | 2007-12-20 |
FI20040674A0 (fi) | 2004-05-12 |
EA010890B1 (ru) | 2008-12-30 |
CA2564033A1 (en) | 2005-11-17 |
EA200602096A1 (ru) | 2007-04-27 |
NO20065669L (no) | 2006-12-08 |
ZA200609304B (en) | 2008-01-30 |
WO2005107757A3 (en) | 2006-01-19 |
AU2005239847B2 (en) | 2010-08-26 |
US8017609B2 (en) | 2011-09-13 |
JP5074923B2 (ja) | 2012-11-14 |
CN1980673B (zh) | 2011-11-23 |
US20110301166A1 (en) | 2011-12-08 |
AU2005239847A1 (en) | 2005-11-17 |
TWI366463B (en) | 2012-06-21 |
NZ550814A (en) | 2009-10-30 |
CN1980673A (zh) | 2007-06-13 |
US20080039467A1 (en) | 2008-02-14 |
KR20080020930A (ko) | 2008-03-06 |
TW200536546A (en) | 2005-11-16 |
EP1744752A2 (en) | 2007-01-24 |
NZ579536A (en) | 2011-03-31 |
WO2005107757A2 (en) | 2005-11-17 |
AR050903A1 (es) | 2006-12-06 |
NZ579537A (en) | 2010-05-28 |
US8329693B2 (en) | 2012-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1107000A1 (en) | A method for the prevention of thromboembolic disorders | |
HK1107821A1 (en) | Method for the production of dihydropteridinones | |
TWI367259B (en) | A method for the detection of chromosomal aneuploidies | |
PT2479680T (pt) | Método para apresentação de streams de velocidade de transmissão adaptável | |
HK1109239A1 (zh) | 維護方法 | |
IL176767A0 (en) | Production method | |
IL188923A0 (en) | Method for predicting the response to a treatment | |
EP1951084A4 (en) | TOOTHBRUSH DEVICE AND METHOD OF MANUFACTURING THEREOF | |
IL191619A0 (en) | Method for purifying fsh or a fsh mutant | |
ZA200803268B (en) | Plants having increased yield and a method for making the same | |
IL184655A0 (en) | Plants having increased yield and a method for making the same | |
IL180893A0 (en) | Method for the preparation of a d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative | |
PL1794111T3 (pl) | Sposób wytwarzania cyklopentanonu | |
GB2445531B (en) | A melt transurethane process for the preparation of polyurethanes | |
HUE036153T2 (hu) | Eljárás poliizocianátok elõállítására | |
GB2430940B (en) | A component forming method | |
EP1907377A4 (en) | PROCESS FOR THE PREPARATION OF ALMOTRIPTANE | |
GB0422378D0 (en) | A method | |
GB0407125D0 (en) | A process | |
GB0407120D0 (en) | A process | |
GB0407124D0 (en) | A process | |
GB0407123D0 (en) | A process | |
TJ16Y3 (en) | A method for total vestibuboplastic of the top jawat adentia | |
ZA200700282B (en) | Method for the production of dihydropteridinones | |
GB0505898D0 (en) | Improved method for the manufacture of a building product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150512 |